Founded in 2016, Sinovent combines its expertise in science, management, and finance to research and develop advanced treatment methods for a range of diseases. With a focus on oncology, auto-immune diseases, and infectious diseases, the company has 12 products in development. Sinovent's advanced biotechnology platform, decades of management experience, and financial support enable them to provide medical solutions that improve patients' overall health. Their research covers therapeutic fields such as tumors, the central nervous system, autoimmunity, and infection, addressing worldwide healthcare problems.